Cargando…
Benefits of nirmatrelvir–ritonavir remain unproven for some populations
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
CMA Impact Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481259/ https://www.ncbi.nlm.nih.gov/pubmed/35918091 http://dx.doi.org/10.1503/cmaj.146689-l |
| _version_ | 1784791224448712704 |
|---|---|
| author | McDonald, Emily G. Lee, Todd |
| author_facet | McDonald, Emily G. Lee, Todd |
| author_sort | McDonald, Emily G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9481259 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | CMA Impact Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94812592022-09-18 Benefits of nirmatrelvir–ritonavir remain unproven for some populations McDonald, Emily G. Lee, Todd CMAJ Letters CMA Impact Inc. 2022-08-02 2022-08-02 /pmc/articles/PMC9481259/ /pubmed/35918091 http://dx.doi.org/10.1503/cmaj.146689-l Text en © 2022 CMA Impact Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| spellingShingle | Letters McDonald, Emily G. Lee, Todd Benefits of nirmatrelvir–ritonavir remain unproven for some populations |
| title | Benefits of nirmatrelvir–ritonavir remain unproven for some populations |
| title_full | Benefits of nirmatrelvir–ritonavir remain unproven for some populations |
| title_fullStr | Benefits of nirmatrelvir–ritonavir remain unproven for some populations |
| title_full_unstemmed | Benefits of nirmatrelvir–ritonavir remain unproven for some populations |
| title_short | Benefits of nirmatrelvir–ritonavir remain unproven for some populations |
| title_sort | benefits of nirmatrelvir–ritonavir remain unproven for some populations |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481259/ https://www.ncbi.nlm.nih.gov/pubmed/35918091 http://dx.doi.org/10.1503/cmaj.146689-l |
| work_keys_str_mv | AT mcdonaldemilyg benefitsofnirmatrelvirritonavirremainunprovenforsomepopulations AT leetodd benefitsofnirmatrelvirritonavirremainunprovenforsomepopulations |